Preclinical Data Has AVR-RD-02 Gene Therapy on Track for First Trial in Humans
News
Avrobio presented updated preclinical data for AVR-RD-02, its gene therapy candidate for Gaucher disease, and announced its plans to begin the first clinical studies in patients with type 1 disease ... Read more